USD 0.08
(14.29%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 32.5 Thousand CAD | -18.75% |
2022 | 40 Thousand CAD | 0.0% |
2021 | 40 Thousand CAD | 0.0% |
2020 | 40 Thousand CAD | -85.71% |
2019 | 280 Thousand CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | -100.0% |
2016 | 345.33 Thousand CAD | 70.39% |
2015 | 202.66 Thousand CAD | 0.0% |
2014 | - CAD | 0.0% |
2013 | - CAD | 0.0% |
2012 | - CAD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q3 | - CAD | -100.0% |
2024 Q2 | 32.5 Thousand CAD | 0.0% |
2024 Q1 | 32.5 Thousand CAD | 0.0% |
2023 Q1 | 40 Thousand CAD | 0.0% |
2023 Q2 | 40 Thousand CAD | 0.0% |
2023 Q3 | 40 Thousand CAD | 0.0% |
2023 FY | 32.5 Thousand CAD | -18.75% |
2023 Q4 | 32.5 Thousand CAD | -18.75% |
2022 Q3 | 40 Thousand CAD | 0.0% |
2022 FY | 40 Thousand CAD | 0.0% |
2022 Q1 | 40 Thousand CAD | 0.0% |
2022 Q2 | 40 Thousand CAD | 0.0% |
2022 Q4 | 40 Thousand CAD | 0.0% |
2021 FY | 40 Thousand CAD | 0.0% |
2021 Q1 | 40 Thousand CAD | 0.0% |
2021 Q2 | 40 Thousand CAD | 0.0% |
2021 Q3 | 40 Thousand CAD | 0.0% |
2021 Q4 | 40 Thousand CAD | 0.0% |
2020 Q3 | - CAD | 0.0% |
2020 FY | 40 Thousand CAD | -85.71% |
2020 Q2 | - CAD | -100.0% |
2020 Q1 | 630 Thousand CAD | 125.0% |
2020 Q4 | 40 Thousand CAD | 0.0% |
2019 FY | 280 Thousand CAD | 0.0% |
2019 Q3 | 180 Thousand CAD | 71.43% |
2019 Q2 | 105 Thousand CAD | 0.0% |
2019 Q4 | 280 Thousand CAD | 55.56% |
2019 Q1 | 105 Thousand CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2018 FY | - CAD | 0.0% |
2018 Q4 | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2018 Q2 | - CAD | 0.0% |
2017 Q2 | 32.72 Thousand CAD | -49.26% |
2017 Q4 | - CAD | 0.0% |
2017 Q1 | 64.48 Thousand CAD | -81.33% |
2017 FY | - CAD | -100.0% |
2017 Q3 | - CAD | -100.0% |
2016 Q3 | 377.99 Thousand CAD | 0.0% |
2016 Q2 | - CAD | 0.0% |
2016 Q4 | 345.33 Thousand CAD | -8.64% |
2016 FY | 345.33 Thousand CAD | 70.39% |
2016 Q1 | - CAD | -100.0% |
2015 Q4 | 202.66 Thousand CAD | 0.0% |
2015 Q2 | - CAD | 0.0% |
2015 Q3 | - CAD | 0.0% |
2015 FY | 202.66 Thousand CAD | 0.0% |
2015 Q1 | - CAD | 0.0% |
2014 Q3 | - CAD | 0.0% |
2014 FY | - CAD | 0.0% |
2014 Q1 | - CAD | 0.0% |
2014 Q4 | - CAD | 0.0% |
2014 Q2 | - CAD | 0.0% |
2013 Q3 | - CAD | 0.0% |
2013 Q1 | - CAD | 0.0% |
2013 Q2 | - CAD | 0.0% |
2013 FY | - CAD | 0.0% |
2013 Q4 | - CAD | 0.0% |
2012 Q4 | - CAD | 0.0% |
2012 FY | - CAD | 0.0% |
2012 Q3 | - CAD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
American Bio Medica Corporation | 2.24 Million USD | 98.549% |
Arrayit Corporation | 1.07 Million USD | 96.986% |
Atlantic International Corp. | 2.93 Million USD | 98.891% |
Biocept, Inc. | 12.1 Million USD | 99.732% |
Bioqual, Inc. | 3.58 Million USD | 99.094% |
CardioGenics Holdings Inc | 72.61 Thousand USD | 55.243% |
DermTech, Inc. | 54.39 Million USD | 99.94% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 99.993% |
HTG Molecular Diagnostics, Inc. | 4.83 Million USD | 99.328% |
iMD Companies, Inc. | 1.12 Million USD | 97.099% |
IDenta Corp. | 789.14 Thousand USD | 95.882% |
Interpace Biosciences, Inc. | 11.19 Million USD | 99.71% |
Integrative Health Technologies, Inc. | - USD | -Infinity% |
InVitro International | 43.84 Thousand USD | 25.875% |
Lumos Diagnostics Holdings Limited | 8.04 Million USD | 99.596% |
Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
Medical Imaging Corp. | 3.82 Million USD | 99.151% |
NovelStem International Corp. | 3.57 Million USD | 99.091% |
Optigenex Inc. | 8.94 Million USD | 99.636% |
PharmChem, Inc. | 77.35 Thousand USD | 57.985% |
Proteome Sciences plc | 17.15 Million USD | 99.811% |
Response Genetics, Inc | 6.37 Million USD | 99.49% |
Rennova Health, Inc. | 15.32 Million USD | 99.788% |
RushNet, Inc. | 4.82 Million USD | 99.326% |
ScreenPro Security Inc. | 207.03 Thousand USD | 84.302% |
Stella Diagnostics Inc. | 6.2 Million USD | 99.476% |
StageZero Life Sciences Ltd. | 1.8 Million USD | 98.195% |
Todos Medical Ltd. | 38.34 Million USD | 99.915% |